Congressman Tim Ryan Applauds Passage of Comprehensive Heroin and Prescription Drug Prevention Legislation
Washington, DC – Congressman Tim Ryan votes in support of comprehensive opioid and heroin prevention legislation – this package of bills passed the House of Representatives today with bipartisan support. In March, the Senate passed the Comprehensive Addiction and Recovery Act (CARA), the differences between the House and Senate versions of this legislation will be worked out in Conference.
“Fatal drug overdose is the leading cause of accidental death in the state of Ohio – in Cuyahoga Country alone, we are seeing an average of one death a day from overdose. Heroin and prescription drug addiction is destroying lives, disrupting families and destabilizing communities here in Ohio and across our nation – I am proud that the House passed legislation today to start stemming this ever-growing tide,” said Congressman Ryan. “As Co-Chair of the Congressional Addiction, Treatment and Recovery Caucus, I understand the tremendous damage substance abuse inflicts – it is unfortunate, but I don’t think I remember a day gone by when I didn’t watch on TV, hear on the radio or see firsthand the toll this epidemic has taken on our communities. This legislation is a step in the right direction, and I will continue to push Congressional leadership to pass emergency funding so we can provide law enforcement officers, public health officials, community leaders, and educators the resources they need to tackle this issue. I promise to continue fighting to put an end to this national tragedy.”
Ryan worked closely with Congressman Jim Sensenbrenner (R-WI) -- who led the Republican efforts on the legislation. Ryan and Sensenbrenner introduced the Comprehensive Opioid Reduction Act of 2016, which is one piece of the larger legislation package. This bill creates a comprehensive opioid abuse reduction program at the Department of Justice that will provide targeted focus on how to tackle the massive problem of substance abuse, including the expansion of prescription drug monitoring programs and resources for veterans treatment court programs.
To watch Ryan speak during debate of comprehensive legislation click here
Ryan is a Co-Chair of the Congressional Addiction, Treatment and Recovery Caucus and a member of the Bipartisan Task Force to Combat the Heroin Epidemic.
Ryan cosponsored the following bills, some of which ended up in the package of bills that passed by the House of Representatives this week:
- Ryan introduced with Congressman Sensenbrenner the Comprehensive Addiction and Recovery Act (HR 953)
- Ryan was an original cosponsor of the Jason Simcakoski PROMISE Act (HR 4063)
- Ryan was a cosponsor of NAS Healthy Babies Act (HR 4978)
- Ryan was a cosponsor of Improving Treatment for Pregnant and Postpartum Women Act of 2016 (HR 3691)
- Ryan was a cosponsor of John Thomas Decker Act of 2016 (HR 4969)
- Ryan was a cosponsor of the Heroin and Prescription Opioid Abuse Prevention, Education and Enforcement Act
- Ryan was an original cosponsor of the Original Cosponsor of Stop Overdose Stat Act of 2015 (HR 2850)
- Ryan was an original cosponsor of the Comprehensive Justice and Mental Health Act (HR 1854)
- Ryan was a cosponsor of the TREAT Act (HR 2536)
- Ryan was an original cosponsor of the Stop Trafficking in Fentanyl Act of 2015 (HR 4183)
- Ryan was an original cosponsor of the Breaking Addiction Act of 2015 (HR 1988)
Ryan has sent the following letters regarding the ongoing opioid and prescription drug epidemic:
- Letter to Speaker Ryan on expediting opioid and heroin legislation and attaching emergency funding to the to this effort.
- Letter to FDA with expressing concerns with the FDA’s decision to approve the opioid prescription painkiller OxyContin for use by children as young as 11 years old.
- Letter to the Drug Enforcement Administration urging the DEA to clarify its existing regulations regarding partially fill opioid prescriptions.
- Letter to Office of Management and Budget, Department of Health and Human Services, and Office of the National Drug Control Policy to call on the Administration to identify sources of funding to help communities purchase and distribute naloxone.